Plus Therapeutics Expands ReSPECT™ Clinical Trial To MD Anderson Cancer Center

Press/Media: Press / Media

PeriodDec 1 2020

Media coverage

11

Media coverage

  • TitlePlus Therapeutics Expands ReSPECT™ Clinical Trial To MD Anderson Cancer Center
    Media name/outletTheStreet.com
    CountryUnited States
    Date12/1/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
    Media name/outletMorningstar.com
    CountryUnited States
    Date12/1/20
    PersonsAndrew Brenner
  • TitleExpands ReSPECT(TM) Clinical Trial to MD Anderson Cancer Center
    Media name/outletMarket News Publishing
    CountryUnited States
    Date12/1/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
    Media name/outletYahoo! Canada
    CountryCanada
    Date12/1/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
    Media name/outletYahoo! Finance
    CountryUnited States
    Date12/1/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Expands ReSPECT ™ Clinical Trial to MD Anderson Cancer Center
    Media name/outletStockwatch
    CountryCanada
    Date12/1/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
    Media name/outletCrwe World
    CountryUnited States
    Date12/1/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
    Media name/outletBioSpace
    CountryUnited States
    Date12/1/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Expands ReSPECT„¢ Clinical Trial to MD Anderson Cancer Center
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date12/1/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
    Media name/outletGlobeNewswire
    CountryUnited States
    Date12/1/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
    Media name/outletBizWire Express
    CountryIndia
    Date12/1/20
    PersonsAndrew Brenner